Trulieve Cannabis Corp. logo TCNNF - Trulieve Cannabis Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $47.21 DETAILS
HIGH: $65.00
LOW: $18.00
MEDIAN: $52.92
CONSENSUS: $47.21
UPSIDE: 437.75%

Stock News

3 Marijuana Stocks To Watch In 2026 That Could Soon Rise In Trading

3 Marijuana Stocks To Watch In 2026 That Could Soon Rise In Trading

With the continued growth and expansion of the cannabis industry, companies are witnessing another shift. Between the USA and Canada, more companies are focused on better branding and marketing attached to better quality products. Right now, in legal cannabis, it is the battle of genetics and who has what and who is inside their legal facilities. As cannabis becomes more mainstream, consumers, like anything else, want reliable products from top brands.

Jun 22, 2026 08:06 AM marijuanastocks.com
3 Leading Marijuana Stocks Investors Are Watching in June 2026

3 Leading Marijuana Stocks Investors Are Watching in June 2026

The cannabis sector continues evolving as operators focus on profitability, cash flow, and market expansion. Federal cannabis reform discussions remain a major catalyst. Meanwhile, leading multistate operators continue strengthening their positions across key U.S. markets. Investors searching for cannabis exposure may want to focus on companies with strong retail footprints and improving financial performance.

Jun 09, 2026 06:00 AM marijuanastocks.com
Trulieve Announces Share Repurchase Program

Trulieve Announces Share Repurchase Program

TALLAHASSEE, Fla., June 9, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase up to the lesser of (i) $50 million in aggregate value, and (ii) 8,495,038 subordinate voting shares of the Company (being five percent (5%) of the Company's issued and outstanding subordinate voting shares as at June 8, 2026) over a 12-month period.

Jun 09, 2026 04:00 AM prnewswire.com
Trulieve Announces Uplist to NYSE

Trulieve Announces Uplist to NYSE

Subordinate Voting Shares expected to begin trading under ticker "TRLV" on Wednesday, June 10 TALLAHASSEE, Fla., June 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its subordinate voting shares (the "Subordinate Voting Shares") have been approved for listing on the New York Stock Exchange ("NYSE").

Jun 05, 2026 03:00 AM prnewswire.com
3 Marijuana Stocks To Know About Now In 2026

3 Marijuana Stocks To Know About Now In 2026

The cannabis industry once again is going through some big changes. Nearly every state in the USA has some form of legal cannabis legislation. Now, with the recent passing of cannabis being considered a class 3 substance, companies are preparing for the future. This preparation is making the necessary adjustments for businesses to take advantage of this new law. Some companies are forming partnerships to evolve further and take their place at the forefront of the sector.

May 18, 2026 06:43 AM marijuanastocks.com
Trulieve Announces Proposed Domestication from British Columbia to Delaware

Trulieve Announces Proposed Domestication from British Columbia to Delaware

TALLAHASSEE, Fla., May 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that the Company will be seeking shareholder approval of a proposed plan of arrangement (the "Arrangement") which involves the continuance of the Company out from the province of British Columbia, Canada, and the concurrent domestication of the Company to the State of Delaware in the United States (the "Domestication").

May 13, 2026 12:46 PM prnewswire.com
Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation

Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation

First quarter revenue of $287 million, with 59% gross margin Positive net income of $2 million and Adjusted EBITDA of $100 million* Rescheduling of medical marijuana to Schedule III enabled applications for DEA registration  TALLAHASSEE, Fla., May 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended March 31, 2026.

May 07, 2026 02:15 AM prnewswire.com
Top Marijuana Stocks and Investment Outlook 2026

Top Marijuana Stocks and Investment Outlook 2026

The cannabis industry in the United States is entering a new phase of sustained growth, positioning itself as one of the most closely watched emerging sectors for both investors and industry professionals. As legalization continues to expand at the state level, the legal framework supporting the cannabis industry is becoming stronger and more normalized. With only a handful of states yet to adopt full medical or adult-use programs, cannabis is approaching near-national acceptance, significantly increasing the total addressable market.

May 04, 2026 09:20 AM marijuanastocks.com
Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses

Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses

TALLAHASSEE, Fla., April 29, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state‑licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.

Apr 29, 2026 11:43 AM prnewswire.com

Price Targets